YLR413W Antibody

What is YLR413W and why is it important for yeast research?

YLR413W is a protein encoded by the Saccharomyces cerevisiae genome. This antibody targets the YLR413W protein (UniProt ID: Q06689) present in Baker's yeast (strain ATCC 204508/S288c) . The importance of studying this protein lies in understanding fundamental cellular processes in yeast, which serves as a model organism for eukaryotic cell biology. Methodologically, researchers should approach YLR413W studies through comparative analysis with other model organisms to identify conserved cellular mechanisms.

What are the validated applications for YLR413W antibody?

The YLR413W antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications . For Western blot procedures, researchers should follow protocols similar to those established by YCharOS, which involve running wild-type cell lysates alongside knockout controls to validate specificity . The antibody has been antigen affinity-purified, making it suitable for detecting the native protein in yeast extracts with high specificity .

What are the optimal storage and handling conditions for YLR413W antibody?

The YLR413W antibody should be stored at -20°C or -80°C immediately upon receipt. Researchers should avoid repeated freeze-thaw cycles as this can degrade antibody quality . The antibody is supplied in liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative, 50% glycerol, and 0.01M PBS at pH 7.4 . For experimental use, aliquoting the antibody into single-use volumes is recommended to maintain long-term stability and functionality.

How should I design control experiments when using YLR413W antibody?

Based on established best practices for antibody validation, experimental designs should include:

Control Table for YLR413W Antibody Experiments:

Experimental data should show clear differences between wild-type and knockout samples, with signals appearing only in wild-type samples at the expected molecular weight .

What is the recommended protocol for Western blot using YLR413W antibody?

When conducting Western blot experiments with YLR413W antibody, researchers should:

• Prepare yeast lysates using methods that preserve protein integrity (glass bead lysis or enzymatic digestion)

• Resolve proteins using SDS-PAGE (10-12% gels typically work well for most yeast proteins)

• Transfer proteins to PVDF or nitrocellulose membranes

• Block with 5% non-fat milk or BSA in TBST

• Incubate with YLR413W antibody at an optimized dilution (initial testing at 1:1000 is recommended)

• Wash thoroughly with TBST

• Incubate with appropriate HRP-conjugated secondary antibody

• Develop using enhanced chemiluminescence

Always include wild-type and YLR413W deletion strains as positive and negative controls respectively to validate specificity .

How can I integrate YLR413W antibody into quantitative proteomics workflows?

The YLR413W antibody can be incorporated into quantitative proteomics studies using methodologies similar to those described for motif-specific antibodies in yeast . This approach would involve:

• SILAC labeling of yeast cultures grown in different conditions (e.g., glucose vs. ethanol media)

• Proteolytic digestion of extracted proteins

• Immunoprecipitation of peptides using the YLR413W antibody

• LC-MS/MS analysis of enriched peptides

• Quantitative comparison of peptide abundance across conditions

This method has demonstrated high reproducibility and sensitivity in yeast proteome studies, allowing detection of differential expression patterns in response to environmental changes .

How can YLR413W antibody be utilized to study protein-protein interactions in yeast?

For investigating protein-protein interactions involving YLR413W:

• Co-immunoprecipitation (Co-IP): Use YLR413W antibody to pull down the protein along with its interaction partners

  • Crosslink cells if detecting transient interactions

  • Lyse cells under non-denaturing conditions

  • Incubate lysate with YLR413W antibody

  • Capture antibody-protein complexes with Protein A/G beads

  • Elute and analyze interacting proteins by Western blot or mass spectrometry

• Proximity Labeling: Combine with BioID or APEX2 systems to identify proximal proteins in living cells

• ChIP-seq: If YLR413W has nuclear functions, characterize DNA binding sites through chromatin immunoprecipitation

These approaches should be validated using appropriate controls, including isotype controls and YLR413W deletion strains .

What strategies can be used to incorporate YLR413W antibody into studies of yeast stress response pathways?

To investigate YLR413W's role in stress response:

• Differential Expression Analysis: Compare YLR413W protein levels in stress vs. normal conditions using quantitative Western blot

  • Expose yeast to various stressors (oxidative, DNA damage, heat shock)

  • Extract proteins at different time points

  • Quantify YLR413W levels using the antibody

• Subcellular Localization: Track YLR413W localization changes during stress response

  • Perform fractionation followed by Western blot analysis

  • Compare with GFP-tagged strains to confirm results

• Pathway Analysis: Combine with studies of known stress response factors

  • Compare phenotypes of YLR413W mutants with other mutants in DNA repair

  • Evaluate sensitization to ROS-inducing agents like those described in studies of genotoxic mechanisms

This multi-faceted approach can reveal functional relationships between YLR413W and established stress response pathways.

How can the YLR413W antibody be adapted for multiplexed detection systems?

For multiplexed detection:

• Direct Labeling: Conjugate YLR413W antibody with fluorophores, enzymes, or metals

  • Use commercial conjugation kits compatible with rabbit polyclonal antibodies

  • Validate that conjugation doesn't affect epitope binding

• Sequential Multiplexed Immunodetection:

  • Apply stripping and reprobing methods for Western blots

  • Utilize tyramide signal amplification for increased sensitivity

• Mass Cytometry/CyTOF:

  • Label with metal isotopes for single-cell analysis if studying yeast populations

  • Combine with antibodies against other proteins for pathway analysis

These approaches should be thoroughly validated using specificity controls as demonstrated in antibody characterization studies .

How should I address non-specific binding issues with YLR413W antibody?

When encountering non-specific binding:

• Optimization Strategies:

  • Increase blocking time/concentration (5-10% BSA or milk)

  • Test different blocking agents (BSA, milk, commercial blockers)

  • Optimize antibody dilution (try 1:500 to 1:5000 range)

  • Increase washing stringency (higher salt or detergent concentration)

  • Try alternative membrane types

• Validation Approaches:

  • Always include YLR413W deletion strains as negative controls

  • Pre-absorb antibody with recombinant YLR413W protein to confirm specificity

  • Compare binding patterns with publicly available antibody characterization data

Non-specific binding is a common challenge with polyclonal antibodies, which generally perform less well than recombinant antibodies in specificity tests .

What are the best practices for quantitative analysis of Western blot data using YLR413W antibody?

For rigorous quantitative analysis:

• Experimental Design Requirements:

  • Include a dilution series of samples to establish linear detection range

  • Run technical replicates (minimum n=3) for statistical analysis

  • Include internal loading controls for normalization

• Data Acquisition and Analysis:

  • Use calibrated digital imaging systems rather than film

  • Avoid saturated signals that fall outside the linear range

  • Normalize to loading controls using validated software

  • Apply appropriate statistical tests for comparing conditions

• Reporting Standards:

  • Include representative blot images showing all controls

  • Report both normalized and raw data values

  • Document all image adjustments applied during analysis

These practices align with recommendations from antibody validation initiatives and ensure reproducible, quantitative results .

How can I interpret contradictory results between YLR413W antibody detection and other methods like RNA-seq or mass spectrometry?

When facing contradictory results:

• Systematic Troubleshooting Approach:

• Resolution Strategies:

  • Verify antibody binding site accessibility in your experimental conditions

  • Consider post-translational modifications that might affect antibody recognition

  • Use orthogonal detection methods like mass spectrometry targeting multiple peptides

  • Implement genetic tagging approaches (HA, FLAG) to compare with antibody results

• Integration Framework:

  • Develop a weighted evidence approach that considers technical limitations of each method

  • Design experiments that can specifically address discrepancies

  • Consider the biological context when interpreting contradictions

Contradictory results often provide valuable insights into protein regulation or experimental limitations rather than simply representing errors .

How can YLR413W antibody be integrated into emerging single-cell analysis technologies?

The adaptation of YLR413W antibody for single-cell studies could involve:

• Single-Cell Western Blotting:

  • Optimize antibody concentration for microfluidic single-cell Western systems

  • Establish detection limits and dynamic range at single-cell resolution

• Mass Cytometry Applications:

  • Metal-conjugated YLR413W antibody for CyTOF analysis of yeast populations

  • Integration with yeast fixation and permeabilization protocols

• Spatial Proteomics:

  • Adapt for multiplexed imaging methodologies

  • Combine with subcellular markers to map YLR413W localization patterns

These approaches would enable studying cell-to-cell variability in YLR413W expression and localization, particularly relevant for understanding heterogeneous responses in yeast populations.

What considerations should be made when adapting YLR413W antibody for CRISPR-based functional genomic screens?

When integrating YLR413W antibody into CRISPR screens:

• Validation Requirements:

  • Verify antibody performance in fixed/permeabilized cells for intracellular staining

  • Establish detection thresholds for distinguishing knockout from wild-type cells

• Screening Workflow Integration:

  • Design pooled CRISPR libraries targeting YLR413W interactors

  • Use antibody-based sorting to isolate cells with altered YLR413W levels or localization

  • Implement sequencing readouts to identify genetic modifiers

• Data Analysis Framework:

  • Develop quantitative metrics for antibody-based phenotypes

  • Establish statistical methods for identifying true hits versus technical artifacts

This integration would enable unbiased discovery of genetic factors affecting YLR413W expression, localization, or function.